Listed

Angiodynamics Inc: Form 10-Q for the period ended Nov 30, 2016

Filed with the SEC on Jan 6, 2017 and accepted by EDGAR at Jan 6, 2017, 15:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-11-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue6 months2016-06-01 to 2016-11-30$177.1mus-gaap:SalesRevenueNet
Cost of revenue3 months2016-09-01 to 2016-11-30$44.0mus-gaap:CostOfGoodsSold
Cost of revenue6 months2016-06-01 to 2016-11-30$87.1mus-gaap:CostOfGoodsSold
Gross profit3 months2016-09-01 to 2016-11-30$45.0mus-gaap:GrossProfit
Gross profit6 months2016-06-01 to 2016-11-30$90.0mus-gaap:GrossProfit
Research and development3 months2016-09-01 to 2016-11-30$5.9mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2016-06-01 to 2016-11-30$12.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-09-01 to 2016-11-30$15.6mus-gaap:OperatingIncomeLoss
Operating income6 months2016-06-01 to 2016-11-30$19.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-09-01 to 2016-11-30$813.0kus-gaap:InterestExpense
Interest expense6 months2016-06-01 to 2016-11-30$1.5mus-gaap:InterestExpense
Income tax3 months2016-09-01 to 2016-11-30$681.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2016-06-01 to 2016-11-30$2.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-09-01 to 2016-11-30$13.7mus-gaap:NetIncomeLoss
Net income6 months2016-06-01 to 2016-11-30$15.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-09-01 to 2016-11-30$0.37us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2016-06-01 to 2016-11-30$0.41us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-09-01 to 2016-11-30$0.37us-gaap:EarningsPerShareBasic
Basic EPS6 months2016-06-01 to 2016-11-30$0.41us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-09-01 to 2016-11-3037,146,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2016-06-01 to 2016-11-3037,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2016-06-01 to 2016-11-30$22.4mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2016-06-01 to 2016-11-30$1.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2016-06-01 to 2016-11-30$7.8mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-11-30$35.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-11-30$147.8mus-gaap:AssetsCurrent
Total assetsAt period end2016-11-30$712.2mus-gaap:Assets
Current liabilitiesAt period end2016-11-30$50.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-11-30$188.8mus-gaap:Liabilities
Long-term debtAt period end2016-11-30$110.2mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2016-11-30$5.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2016-11-30$523.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001275187-17-000005. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.